BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohit E, Hashemi A, Allahyari M. Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines. Expert Review of Clinical Immunology 2014;10:927-61. [DOI: 10.1586/1744666x.2014.916211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Karami K, Anbari K. Breast Cancer: A Review of Risk Factors and New Insights into Treatment. CCTR 2021;17:207-33. [DOI: 10.2174/1573394717999210120195208] [Reference Citation Analysis]
2 Khan WA, Khan MWA, Sherwani S, Siddiqui WA. Depression enhanced the production of autoantibodies against 16α‑hydroxyestrone-estrogen receptor adduct in breast cancer. International Immunopharmacology 2019;66:251-9. [DOI: 10.1016/j.intimp.2018.11.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Karami Fath M, Babakhaniyan K, Zokaei M, Yaghoubian A, Akbari S, Khorsandi M, Soofi A, Nabi-Afjadi M, Zalpoor H, Jalalifar F, Azargoonjahromi A, Payandeh Z, Alagheband Bahrami A. Anti-cancer peptide-based therapeutic strategies in solid tumors. Cell Mol Biol Lett 2022;27:33. [PMID: 35397496 DOI: 10.1186/s11658-022-00332-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cordeiro AS, Alonso MJ, de la Fuente M. Nanoengineering of vaccines using natural polysaccharides. Biotechnol Adv 2015;33:1279-93. [PMID: 26049133 DOI: 10.1016/j.biotechadv.2015.05.010] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
5 Gornowicz A, Bielawska A, Czarnomysy R, Gabryel-Porowska H, Muszyńska A, Bielawski K. The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells. Mol Cell Biochem 2015;408:103-13. [PMID: 26112902 DOI: 10.1007/s11010-015-2486-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
6 Hosseinzadeh A, Merikhian P, Naseri N, Eisavand MR, Farahmand L. MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02523-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xiao YF, Jie MM, Li BS, Hu CJ, Xie R, Tang B, Yang SM. Peptide-Based Treatment: A Promising Cancer Therapy. J Immunol Res 2015;2015:761820. [PMID: 26568964 DOI: 10.1155/2015/761820] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
8 Liu Y, Tang L, Gao N, Diao Y, Zhong J, Deng Y, Wang Z, Jin G, Wang X. Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects. Oncol Lett 2020;20:2369-77. [PMID: 32782554 DOI: 10.3892/ol.2020.11762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhang L, Huang Y, Lindstrom AR, Lin TY, Lam KS, Li Y. Peptide-based materials for cancer immunotherapy. Theranostics 2019;9:7807-25. [PMID: 31695802 DOI: 10.7150/thno.37194] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
10 García-Aranda M, Redondo M. Immunotherapy: A Challenge of Breast Cancer Treatment. Cancers (Basel) 2019;11:E1822. [PMID: 31756919 DOI: 10.3390/cancers11121822] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
11 Zhang L, Zhu X, Wu S, Chen Y, Tan S, Liu Y, Jiang W, Huang J. Fabrication and evaluation of a γ-PGA-based self-assembly transferrin receptor-targeting anticancer drug carrier. Int J Nanomedicine 2018;13:7873-89. [PMID: 30538465 DOI: 10.2147/IJN.S181121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
12 Naeimi R, Bahmani A, Afshar S. Investigating the role of peptides in effective therapies against cancer. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02553-7] [Reference Citation Analysis]